Linehan WM - Search Results

1

A Phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer.

Bergan RC, Reed E, Myers CE, Headlee D, Brawley O, Cho HK, Figg WD, Tompkins A, Linehan WM, Kohler D, Steinberg SM, Blagosklonny MV. Bergan RC, et al. Among authors: linehan wm. Clin Cancer Res. 1999 Sep;5(9):2366-73. Clin Cancer Res. 1999. PMID: 10499606 Clinical Trial.

2

Suramin interference with transforming growth factor-beta inhibition of human renal cell carcinoma in culture.

Wade TP, Kasid A, Stein CA, LaRocca RV, Sargent ER, Gomella LG, Myers CE, Linehan WM. Wade TP, et al. Among authors: linehan wm. J Surg Res. 1992 Aug;53(2):195-8. doi: 10.1016/0022-4804(92)90034-w. J Surg Res. 1992. PMID: 1405609

3

Suramin inhibits bone resorption and reduces osteoblast number in a neonatal mouse calvarial bone resorption assay.

Walther MM, Kragel PJ, Trahan E, Venzon D, Blair HC, Schlesinger PH, Jamai-Dow C, Ewing MW, Myers CE, Linehan WM. Walther MM, et al. Among authors: linehan wm. Endocrinology. 1992 Nov;131(5):2263-70. doi: 10.1210/endo.131.5.1425426. Endocrinology. 1992. PMID: 1425426

4

Effect of suramin on human prostate cancer cells in vitro.

La Rocca RV, Danesi R, Cooper MR, Jamis-Dow CA, Ewing MW, Linehan WM, Myers CE. La Rocca RV, et al. Among authors: linehan wm. J Urol. 1991 Feb;145(2):393-8. doi: 10.1016/s0022-5347(17)38351-9. J Urol. 1991. PMID: 1824865

5

The effect of suramin, tumor necrosis factor and interferon gamma on human prostate carcinoma.

Liu S, Ewing MW, Anglard P, Trahan E, La Rocca RV, Myers CE, Linehan WM. Liu S, et al. Among authors: linehan wm. J Urol. 1991 Feb;145(2):389-92. doi: 10.1016/s0022-5347(17)38350-7. J Urol. 1991. PMID: 1899122

6

Use of suramin in treatment of prostatic carcinoma refractory to conventional hormonal manipulation.

LaRocca RV, Cooper MR, Uhrich M, Danesi R, Walther MM, Linehan WM, Myers CE. LaRocca RV, et al. Among authors: linehan wm. Urol Clin North Am. 1991 Feb;18(1):123-9. Urol Clin North Am. 1991. PMID: 1992566 Review.

7

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors.

Ozols RF, Ihde DC, Linehan WM, Jacob J, Ostchega Y, Young RC. Ozols RF, et al. Among authors: linehan wm. J Clin Oncol. 1988 Jun;6(6):1031-40. doi: 10.1200/JCO.1988.6.6.1031. J Clin Oncol. 1988. PMID: 2453619 Clinical Trial.

8

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients.

Rosenberg SA, Lotze MT, Yang JC, Aebersold PM, Linehan WM, Seipp CA, White DE. Rosenberg SA, et al. Among authors: linehan wm. Ann Surg. 1989 Oct;210(4):474-84; discussion 484-5. doi: 10.1097/00000658-198910000-00008. Ann Surg. 1989. PMID: 2679456 Free PMC article.

9

Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer.

Rosenberg SA, Lotze MT, Yang JC, Linehan WM, Seipp C, Calabro S, Karp SE, Sherry RM, Steinberg S, White DE. Rosenberg SA, et al. Among authors: linehan wm. J Clin Oncol. 1989 Dec;7(12):1863-74. doi: 10.1200/JCO.1989.7.12.1863. J Clin Oncol. 1989. PMID: 2685181 Clinical Trial.

10

Renal toxicity of interleukin-2 administration in patients with metastatic renal cell cancer: effect of pre-therapy nephrectomy.

Belldegrun A, Webb DE, Austin HA 3rd, Steinberg SM, Linehan WM, Rosenberg SA. Belldegrun A, et al. Among authors: linehan wm. J Urol. 1989 Mar;141(3):499-503. doi: 10.1016/s0022-5347(17)40872-x. J Urol. 1989. PMID: 2783983

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

816 results

Search Page

Filters